Skip to content

Clinical trials

Phase 2 Stomach Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 2 Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20121
20141
20151
20171
20183
20192
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Amgen1
Apollomics Inc.1
AstraZeneca1
Bayer1
BeiGene1
Cancer Therapeutics Research Group1
Daiichi Sankyo1
Eli Lilly and Company1
Five Prime Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms17
Pancreatic Neoplasms5
Breast Neoplasms4
Biliary Tract Neoplasms3
Endometrial Neoplasms3
Ovarian Neoplasms3
Colorectal Neoplasms2
Esophageal Neoplasms2
Glioblastoma2
Kidney Neoplasms2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.